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Background: To what extent hypertension guidelines are adhered to by primary care physicians is unclear. We characterized risk factors, treatment 
patterns and BP control rates in subjects with uncomplicated hypertension in the PARADIGM study.
Methods: PARADIGM enrolled 3015 subjects (men≥40, women ≥50) in an observational registry in Canada. Patients with diabetes, vascular 
disease, or those receiving lipid lowering drugs were excluded. We report on the 917 subjects with hypertension, a purely primary prevention cohort.
Results: Median age was 59+/-9y and 420 (46%) were women. Mean treated BP was 133+/-14 mmHg systolic and 81+/-9 mmHg diastolic. CV 
risk factors included past/current smoking (36%), abdominal obesity (63%) and dyslipidemia (33%). Using the total CV Framingham Risk Score, 
20%, 41% and 39% of subjects were at low, intermediate and high risk respectively. In treated subjects, 47% and 39% were receiving either mono 
or dual antihypertensive therapy, with 14% receiving > 3 drugs. In monotherapy the use of ACEi was 39%, ARB 30%, diuretics 17% and CCB 7%. 
The most common combination therapies were ARB/diuretic (39.4%), ACEi/diuretic (32.9%), BB/diuretic (6.2%), and ACEi/CCB (6.2%). The most 
common triple therapies were RAS blocker/CCB/diuretic (60%) and RAS blocker/BB/diuretic (29%). Rates of control were 65.2% (SBP<140), 74.7% 
(DBP<90), and 57.4% (SBP<140 and DBP <90). DBP control was better in women than in men (79.8 vs 70.4%, p=0.002). Overall BP control rates 
were similar in patients receiving mono or dual therapy, and in patients above or below the median age of 59 y. BP control rates were lowest for 
diuretic (53.2%) vs. ACEi or ARB monotherapy (66.5%), p =0.01.
Conclusions: In non-diabetic subjects with uncomplicated HT, CV risk factors are common, particularly abdominal obesity. Despite the absence 
of diabetes or vascular disease, 80% of subjects had intermediate to high modified FRS. The use of RAS-based monotherapy was high, although 
combination therapy with RAS/ diuretic was still favoured over RAS/ CCB. Even in uncomplicated hypertension, BP control rates were only 57.4% and 
were lowest for diuretic monotherapy.
